Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.129
Sell
RSI(14)
31.577
Neutral
STOCH(KDJ)(9,3,3)
27.491
Neutral
ATR(14)
1.903
Low Volatility
CCI(14)
-111.643
Sell
Williams %R
69.675
Sell
TRIX(12,20)
-0.563
Sell
StochRSI(14)
90.709
Buy
Solventum Corp
SOLV64.710USD
+0.070+0.11%
Close 03/26, 16:00（ET）Quotes delayed by 15 min
11.18BMarket Cap
7.24P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Solventum Corp
Currency: USD Updated: 2026-03-25Key Insights
Solventum Corp's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 67 out of 209 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 86.72.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Solventum Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Solventum Corp Highlights
StrengthsRisks
Solventum Corporation is a global healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer needs. The Company’s segments include MedSurg, Dental Solutions, and Health Information System. MedSurg is a provider of solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies Original Equipment Manufacturer (OEM). Dental Solutions is a provider of a comprehensive suite of dental and orthodontic products including brackets, aligners, and restorative cement. Health Information Systems provides healthcare systems with software solutions, including computer-assisted physician documentation, and direct-to-bill and coding automation.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 8.32B.
Undervalued
The company’s latest PE is 7.23, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 129.39M shares, decreasing 1.74% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 412.00 shares of this stock.
Analyst Rating
Based on
15
analysts
Hold
Current Rating
86.722
Target Price
+32.02%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-03-25The current financial score of Solventum Corp is 6.61, ranking 137 out of 209 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 2.00B, representing a year-over-year decrease of 3.71%, while its net profit experienced a year-over-year decrease of 103.23%.
Score
Financials
5.06
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
8.07
Operational Efficiency
7.09
Growth Potential
5.69
Shareholder Returns
7.13
Solventum Corp's Company Valuation
Currency: USD Updated: 2026-03-25The current valuation score of Solventum Corp is 6.51, ranking 160 out of 209 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 7.23, which is 396.64% below the recent high of 35.92 and 6.19% above the recent low of 6.78.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 67/209
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-03-25The current earnings forecast score of Solventum Corp is 6.93, ranking 157 out of 209 in the Healthcare Equipment & Supplies industry. The average price target is 85.00, with a high of 103.00 and a low of 72.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
15
analysts
Hold
Current Rating
86.722
Target Price
+35.44%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
115
Total
6
Median
9
Average
Company name
Ratings
Analysts
Solventum Corp
SOLV
15
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
31
Dexcom Inc
DXCM
31
1
2
3
...
23
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-03-25The current price momentum score of Solventum Corp is 6.72, ranking 101 out of 209 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 74.09 and the support level at 58.99, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
64.970
Sell
MA10
66.166
Sell
MA20
68.010
Sell
MA50
73.489
Sell
MA100
76.570
Sell
MA200
74.866
Sell
Institutional Confidence
Currency: USD Updated: 2026-03-25The current institutional shareholding score of Solventum Corp is 7.00, ranking 81 out of 209 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 74.59%, representing a quarter-over-quarter increase of 10.91%. The largest institutional shareholder is The Vanguard, holding a total of 16.96M shares, representing 9.77% of shares outstanding, with 4.60% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
3M Co
Independent Franchise Partners LLP
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Geode Capital Management, L.L.C.
Boston Partners
1
2
Risk Assessment
Currency: USD Updated: 2026-03-25The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Solventum Corp is 9.03, ranking 14 out of 209 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Solventum Corp’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
Score
Beta vs S&P 500 index
--
VaR
--
240-Day Maximum Drawdown
+25.67%
240-Day Volatility
+28.77%
Return
Best Daily Return
60 days
+3.06%
120 days
+7.91%
5 years
--
Worst Daily Return
60 days
-6.80%
120 days
-6.80%
5 years
--
Sharpe Ratio
60 days
-2.81
120 days
-0.72
5 years
--
Risk Assessment
Maximum Drawdown
240 days
+25.67%
3 years
--
5 years
--
Return-to-Drawdown Ratio
240 days
-0.03
3 years
--
5 years
--
Skewness
240 days
+0.18
3 years
--
5 years
--
Volatility
Realised Volatility
240 days
+28.77%
5 years
--
Standardised True Range
240 days
+2.82%
5 years
--
Downside Risk-Adjusted Return
120 days
-99.67%
240 days
-99.67%
Maximum Daily Upside Volatility
60 days
+19.17%
Maximum Daily Downside Volatility
60 days
+26.12%
Liquidity
Average Turnover Rate
60 days
+0.54%
120 days
+0.63%
5 years
--
Turnover Deviation
20 days
--
60 days
--
120 days
--
Peer Comparison
Healthcare Equipment & Supplies
Solventum Corp
SOLV
6.96 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
ANIK
8.62 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bioventus Inc
BVS
8.32 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
West Pharmaceutical Services Inc
WST
8.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
EW
8.10 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
